In addition, CMA reduces the amount and toxicity of proteins associated with neurodegenerative diseases beyond α-synuclein, such as tau protein in Alzheimer's disease (AD) (12) or Huntingtin protein in Huntington's disease (13). This evidence concerns the gene MAPT and Alzheimer disease.